Feb 2, 2026 05:50AM
Jan 22, 2026 12:30PM
Jan 8, 2026 07:32AM
Dec 19, 2025 07:50AM
Nov 19, 2025 05:23AM
Nov 14, 2025 07:12AM
Nov 14, 2025 06:51AM Trevi Therapeutics (TRVI) PT Raised to $24 at Oppenheimer
Nov 14, 2025 05:57AM
Nov 13, 2025 05:14PM
Nov 13, 2025 04:12PM
Aug 27, 2025 03:21PM
Aug 21, 2025 04:40AM
Aug 7, 2025 04:22PM
Jul 1, 2025 06:48AM Cantor Fitzgerald Starts Trevi Therapeutics (TRVI) at Overweight
Jun 4, 2025 05:56AM
Jun 3, 2025 06:56AM
Jun 3, 2025 06:26AM
Jun 2, 2025 04:03PM
Jun 2, 2025 04:01PM
Jun 2, 2025 12:18PM
Jun 2, 2025 07:00AM Trevi Therapeutics (TRVI) Announces Positive Topline Results from the Phase 2b CORAL Trial
May 28, 2025 06:45AM
May 21, 2025 09:03AM
May 20, 2025 08:03AM
May 20, 2025 07:04AM
May 20, 2025 05:35AM
May 8, 2025 04:22PM
Apr 23, 2025 10:04AM Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
Mar 26, 2025 07:02AM
Mar 19, 2025 07:22AM
Mar 19, 2025 07:13AM
Mar 19, 2025 06:43AM
Mar 18, 2025 04:05PM
Mar 11, 2025 06:42AM
Mar 10, 2025 12:23PM Trevi Therapeutics (TRVI) PT Raised to $20 at Rodman & Renshaw
Mar 10, 2025 11:44AM
Mar 10, 2025 07:46AM
Mar 10, 2025 07:21AM
Mar 10, 2025 07:13AM
Mar 10, 2025 06:22AM
Mar 6, 2025 02:04PM
Feb 20, 2025 09:30AM Trevi Therapeutics (TRVI) PT Raised to $12 at Stifel
Jan 8, 2025 07:36AM
Jan 8, 2025 07:33AM
Dec 16, 2024 07:37AM
Dec 12, 2024 07:30AM
Dec 4, 2024 06:09AM
Dec 3, 2024 04:06PM
Nov 6, 2024 04:34PM Trevi Therapeutics (TRVI) Misses Q3 EPS by 1c
Oct 22, 2024 06:59AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All